Optimistic_B
liked
$Duolingo (DUOL.US)$ strong support around 142-145. historical bounce zones too. probably might get some leaps from there
10
1
Optimistic_B
voted
Columns Wall Street Today: S&P 500 and DJIA Close at Records as WMT and CRWV Gains Outweigh AXP and V Losses
The S&P 500 and Dow-30 hit new closing highs Monday, while the Nasdaq Composite rose as well as strength for big caps like Walmart and CoreWeave outweighed weakness for credit-card giants American Express and Visa.
The $S&P 500 Index (.SPX.US)$ gained 10.99 points (0.2%) to a 6,977.27 best-ever finish, surpassing its previous record set just last Friday.
The $Dow Jones Industrial Average (.DJI.US)$ ...
The $S&P 500 Index (.SPX.US)$ gained 10.99 points (0.2%) to a 6,977.27 best-ever finish, surpassing its previous record set just last Friday.
The $Dow Jones Industrial Average (.DJI.US)$ ...
21
7
5
Optimistic_B
voted
$Oracle (ORCL.US)$
How many years it take to go back 345
How many years it take to go back 345
Optimistic_B
voted
🔑 Quick Takeaways
• Software sector earnings this quarter show strong beats but mixed guidance — those that already reported often gapped up initially then faded, while not-yet-reported names tend to drift upward on sentiment.
• $Oracle (ORCL.US)$ ’s historical earnings pattern + sector sentiment suggests steady bullish bias, supported by strong seasonality and technical structure.
• M...
• Software sector earnings this quarter show strong beats but mixed guidance — those that already reported often gapped up initially then faded, while not-yet-reported names tend to drift upward on sentiment.
• $Oracle (ORCL.US)$ ’s historical earnings pattern + sector sentiment suggests steady bullish bias, supported by strong seasonality and technical structure.
• M...



+10
24
6
3
Optimistic_B
voted
$Novo-Nordisk A/S (NVO.US)$ 's stock price experienced significant volatility within a few days. On November 24 (ET), the company announced the failure of its Phase III clinical trial for oral semaglutide in treating Alzheimer's disease, causing the stock to plummet, with intraday losses exceeding 9%.
The following day, the company released positive Phase II clinical data for its next-generation dual-target d...
The following day, the company released positive Phase II clinical data for its next-generation dual-target d...
30
2
22

![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)